FI55338C - Foerfarande foer framstaellning av terapeutiskt verksamma n-metyl-imidazoler - Google Patents
Foerfarande foer framstaellning av terapeutiskt verksamma n-metyl-imidazolerInfo
- Publication number
- FI55338C FI55338C FI721/71A FI72171A FI55338C FI 55338 C FI55338 C FI 55338C FI 721/71 A FI721/71 A FI 721/71A FI 72171 A FI72171 A FI 72171A FI 55338 C FI55338 C FI 55338C
- Authority
- FI
- Finland
- Prior art keywords
- imidazoler
- verification
- framework
- therapeutic
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measurement Of Velocity Or Position Using Acoustic Or Ultrasonic Waves (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2013793A DE2013793C2 (de) | 1970-03-23 | 1970-03-23 | N-Methyl-imidazol-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI55338B FI55338B (fi) | 1979-03-30 |
| FI55338C true FI55338C (fi) | 1979-07-10 |
Family
ID=5765958
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI721/71A FI55338C (fi) | 1970-03-23 | 1971-03-12 | Foerfarande foer framstaellning av terapeutiskt verksamma n-metyl-imidazoler |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US3787415A (fi) |
| JP (2) | JPS5414107B1 (fi) |
| AT (1) | AT301537B (fi) |
| BE (1) | BE764700A (fi) |
| CA (1) | CA971964A (fi) |
| CH (1) | CH558802A (fi) |
| DE (1) | DE2013793C2 (fi) |
| DK (1) | DK143847C (fi) |
| ES (2) | ES389495A1 (fi) |
| FI (1) | FI55338C (fi) |
| FR (1) | FR2085731B1 (fi) |
| GB (1) | GB1288196A (fi) |
| HU (1) | HU162527B (fi) |
| IE (1) | IE35137B1 (fi) |
| IL (1) | IL36272A0 (fi) |
| NL (1) | NL171269C (fi) |
| NO (1) | NO130536C (fi) |
| SE (1) | SE369602B (fi) |
| SU (1) | SU411688A3 (fi) |
| YU (1) | YU34476B (fi) |
| ZA (1) | ZA711268B (fi) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3928348A (en) * | 1970-03-23 | 1975-12-23 | Bayer Ag | N-methyl-imidazole derivatives and their production |
| US4062959A (en) * | 1970-03-23 | 1977-12-13 | Bayer Aktiengesellschaft | N-methyl-imidazole derivatives for treating mycotic infections |
| DE3130251A1 (de) * | 1981-07-31 | 1983-02-17 | A. Nattermann & Cie GmbH, 5000 Köln | 6-(4-((omega)-(1-imidazolyl)-alkyl)-phenyl)-3-oxo -2,3,4,5-tetrahydro-pyridazine und deren saeureadditionssalze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
| US4384165A (en) * | 1981-09-14 | 1983-05-17 | Motorola, Inc. | Radio frequency shield with force multiplier interconnection fingers for an electromagnetic gasket |
| US4755526A (en) * | 1984-06-18 | 1988-07-05 | Eli Lilly And Company | Method of inhibiting aromatase |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR6915465D0 (pt) * | 1969-03-07 | 1973-01-04 | Bayer Ag | Processo para preparar n-benzimidazois substituidos na posicao alfa por heterociclos penta-membrados com atividade antimicotica |
-
1970
- 1970-03-23 DE DE2013793A patent/DE2013793C2/de not_active Expired
-
1971
- 1971-02-23 IE IE228/71A patent/IE35137B1/xx unknown
- 1971-02-23 IL IL36272A patent/IL36272A0/xx unknown
- 1971-02-25 CH CH277171A patent/CH558802A/xx not_active IP Right Cessation
- 1971-02-26 ZA ZA711268A patent/ZA711268B/xx unknown
- 1971-03-02 US US00120333A patent/US3787415A/en not_active Expired - Lifetime
- 1971-03-04 HU HUBA2549A patent/HU162527B/hu unknown
- 1971-03-09 CA CA107,257A patent/CA971964A/en not_active Expired
- 1971-03-10 DK DK113871A patent/DK143847C/da not_active IP Right Cessation
- 1971-03-12 FI FI721/71A patent/FI55338C/fi active
- 1971-03-17 AT AT229671A patent/AT301537B/de not_active IP Right Cessation
- 1971-03-18 SE SE03524/71A patent/SE369602B/xx unknown
- 1971-03-18 YU YUP701/71A patent/YU34476B/xx unknown
- 1971-03-22 JP JP1611871A patent/JPS5414107B1/ja active Pending
- 1971-03-22 JP JP1611971A patent/JPS554754B1/ja active Pending
- 1971-03-22 NO NO1092/71A patent/NO130536C/no unknown
- 1971-03-23 SU SU711649401D patent/SU411688A3/ru active
- 1971-03-23 BE BE764700A patent/BE764700A/xx not_active IP Right Cessation
- 1971-03-23 ES ES389495A patent/ES389495A1/es not_active Expired
- 1971-03-23 NL NLAANVRAGE7103889,A patent/NL171269C/xx not_active IP Right Cessation
- 1971-03-23 FR FR7110219A patent/FR2085731B1/fr not_active Expired
- 1971-04-19 GB GB2468671A patent/GB1288196A/en not_active Expired
- 1971-05-18 ES ES391297A patent/ES391297A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NL171269C (nl) | 1983-03-01 |
| ZA711268B (en) | 1971-11-24 |
| FR2085731B1 (fi) | 1974-09-27 |
| SU411688A3 (fi) | 1974-01-15 |
| FI55338B (fi) | 1979-03-30 |
| ES391297A1 (es) | 1973-07-01 |
| FR2085731A1 (fi) | 1971-12-31 |
| NO130536B (fi) | 1974-09-23 |
| JPS554754B1 (fi) | 1980-01-31 |
| ES389495A1 (es) | 1973-06-01 |
| DK143847B (da) | 1981-10-19 |
| NL7103889A (fi) | 1971-09-27 |
| NO130536C (fi) | 1975-01-08 |
| JPS5414107B1 (fi) | 1979-06-05 |
| CA971964A (en) | 1975-07-29 |
| DK143847C (da) | 1982-04-05 |
| AT301537B (de) | 1972-09-11 |
| YU70171A (en) | 1979-02-28 |
| DE2013793C2 (de) | 1983-02-03 |
| BE764700A (fr) | 1971-09-23 |
| GB1288196A (fi) | 1972-09-06 |
| CH558802A (de) | 1975-02-14 |
| IE35137L (en) | 1971-09-23 |
| IL36272A0 (en) | 1971-04-28 |
| IE35137B1 (en) | 1975-11-26 |
| NL171269B (nl) | 1982-10-01 |
| US3787415A (en) | 1974-01-22 |
| YU34476B (en) | 1979-09-10 |
| DE2013793A1 (de) | 1971-10-28 |
| HU162527B (fi) | 1973-03-28 |
| SE369602B (fi) | 1974-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI54916C (fi) | Foerfarande foer framstaellning av terapeutiskt verksamma n-substituerade 2-pyrrolidoner | |
| FI53940C (fi) | Foerfarande och anordning foer framstaellning av en polymerskumstroem | |
| FI54301C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara kinazolinderivat | |
| SE400083B (sv) | Forfarande for framstellning av humant karcinoembryonalt antigen | |
| FI55184C (fi) | Foerfarande foer framstaellning av terapeutiskt verksamma fenyl-2-pyrrolidinoner samt deras isomerer | |
| SE399701B (sv) | Forfarande for framstellning av hydroxyalkyldiamin | |
| FI54100B (fi) | Foerfarande foer framstaellning av terapeutiskt vaerdefulla tricykliska foereningar | |
| SE394436B (sv) | Forfarande for framstellning av 7-halogen-linkomyciner | |
| FI54602C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 6-amidinopenicillansyraderivat | |
| FI54104B (fi) | Foerfarande foer framstaellning av terapeutiskt verksamma pyrrolidinonfoereningar | |
| FI55338B (fi) | Foerfarande foer framstaellning av terapeutiskt verksamma n-metyl-imidazoler | |
| SE385011B (sv) | Forfarande for framstellning av alfa-linkosaminider | |
| FI55503B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara pyrimidinonderivat | |
| FI53967C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara bensobicykloalkanaminer | |
| FI54672C (fi) | Foerfarande foer framstaellning av livsmedel med groenmoegelarom | |
| SE408418B (sv) | Forfarande for framstellning av 5-fluor-pyrimidiner | |
| SE395699B (sv) | Forfarande for framstellning av kinuklidin-kinolinderivat | |
| FI53700C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara diaminopropiofenonderivat | |
| SE380795B (sv) | Forfarande for framstellning av tiokarbamider | |
| SE382046B (sv) | Forfarande for framstellning av 1-aryloxi-2-propanol | |
| FI55509C (fi) | Foerfarande foer framstaellning av indolderivat med antiinflammatoriska egenskaper | |
| FI56171B (fi) | Foerfarande foer framstaellning av terapeutiskt aktiva asylerade piperidin-, tetrahydropyridin- och pyridinderivat | |
| SE382057B (sv) | Forfarande for framstellning av n-hydroxialkylpiperazinylderivat | |
| SE381870B (sv) | Forfarande for framstellning av vissa angivna terapeutiskt anvendbara butyramidiner | |
| SE404607B (sv) | Forfarande for framstellning av optiskt aktiva steroider |